相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
RECK - a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer
Jonathan C. M. Clark et al.
CANCER AND METASTASIS REVIEWS (2007)
In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts
LM Haupt et al.
BMC CANCER (2006)
Gene expression perturbation in vitro - A growing case for three-dimensional (3D) culture systems
A Birgersdotter et al.
SEMINARS IN CANCER BIOLOGY (2005)
Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer
K Takenaka et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines
BE Bachmeier et al.
EXPERIMENTAL CELL RESEARCH (2005)
Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer
AS Schrohl et al.
CLINICAL CANCER RESEARCH (2004)
TIMPs as multifacial proteins
E Lambert et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer
K Takenaka et al.
EUROPEAN JOURNAL OF CANCER (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Friends or foes - Bipolar effects of the tumour stroma in cancer
MM Mueller et al.
NATURE REVIEWS CANCER (2004)
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma
HC Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
A Talvensaari-Mattila et al.
BRITISH JOURNAL OF CANCER (2003)
Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs - A prognostic marker for good clinical outcome in human breast carcinoma
PN Span et al.
CANCER (2003)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Cell signaling events: a view from the matrix
F Ramirez et al.
MATRIX BIOLOGY (2003)
Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer
AS Schrohl et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
RECKing MMP function: implications for cancer development
JS Rhee et al.
TRENDS IN CELL BIOLOGY (2002)
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
J Oh et al.
CELL (2001)
The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis
C Chang et al.
TRENDS IN CELL BIOLOGY (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro
M Balduyck et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
Molecular biology of breast cancer metastasis - Genetic regulation of human breast carcinoma metastasis
DR Welch et al.
BREAST CANCER RESEARCH (2000)
分享论文
